CTBS Terms 15th Edition 2025/2026
Exam Questions with 100% Correct
Answers | Latest Update
Accident - 🧠 ANSWER ✔✔Any occurrence, not associated with a deviation
from standard operating procedures (SOPs), standards, or applicable laws
and regulations, during donor screening or testing, or tissue recovery,
collection or acquisition, processing, quarantining, labeling, storage,
distribution, or dispensing that may affect the performance, biocompatibility,
or freedom from transmissible pathogens of the tissue or the ability to trace
tissue to the donor.
Adverse Outcome - 🧠 ANSWER ✔✔An undesirable effect or untoward
complication in a recipient consequent to or reasonably related to tissue
transplantation.
,Allogeneic - 🧠 ANSWER ✔✔Used as an adjective to modify donation,
tissue, donor or recipient when transplantation is intended for a genetically
different person.
Aortoiliac graft (C) - 🧠 ANSWER ✔✔The distal segment of the abdominal
aorta including the bifurcation and proximal segments of both the left and
right common iliac arteries.
Arterial graft (V) - 🧠 ANSWER ✔✔A segment of peripheral artery that is
recovered, processed and preserved.
Autograft (A) - 🧠 ANSWER ✔✔Tissue intended for implantation,
transplantation or infusion into the living donor from whom it was
recovered.
Available for Distribution - 🧠 ANSWER ✔✔the status of an HCT/P upon
verifying and documenting that the HCT/P meets the release criteria on the
basis of a review of manufacturing and tracking records pertaining to the
HCT/P, documented by a responsible person with the date when the
determination that the HCT/P is available for distribution has been made.
Batch - 🧠 ANSWER ✔✔A specific quantity of tissue produced according to
a single processing protocol during the same processing cycle
, Bioburden - 🧠 ANSWER ✔✔The number of contaminating organisms found
on a given amount of material
Birth Tissue (BT) - 🧠 ANSWER ✔✔gestational tissue donated at the time of
delivery of a living newborn. This includes placenta, Wharton's jelly,
amniotic fluid, chorionic membrane, amniotic membrane,
placental/chorionic disc, umbilical veins, and umbilical cord tissue
Cardiac Tissue (C) - 🧠 ANSWER ✔✔Tissue type that includes, but is not
limited to, valved conduits, non-valved conduits, aortoiliac grafts, and patch
grafts
Cellular Tissue (CT) - 🧠 ANSWER ✔✔viable cells that are autologous or
allogeneic, committed or uncommitted, and non-expanded
Cold Ischemic Time (C) - 🧠 ANSWER ✔✔The time interval from subjecting
cardiac tissue to cold rinse (or transport) solution at recovery to the
beginning of disinfection.
Cold Ischemic Time (V) - 🧠 ANSWER ✔✔The time interval from subjecting
vascular tissue to transport solution and wet ice temperatures at recovery
to the beginning of disinfection.
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
3
Exam Questions with 100% Correct
Answers | Latest Update
Accident - 🧠 ANSWER ✔✔Any occurrence, not associated with a deviation
from standard operating procedures (SOPs), standards, or applicable laws
and regulations, during donor screening or testing, or tissue recovery,
collection or acquisition, processing, quarantining, labeling, storage,
distribution, or dispensing that may affect the performance, biocompatibility,
or freedom from transmissible pathogens of the tissue or the ability to trace
tissue to the donor.
Adverse Outcome - 🧠 ANSWER ✔✔An undesirable effect or untoward
complication in a recipient consequent to or reasonably related to tissue
transplantation.
,Allogeneic - 🧠 ANSWER ✔✔Used as an adjective to modify donation,
tissue, donor or recipient when transplantation is intended for a genetically
different person.
Aortoiliac graft (C) - 🧠 ANSWER ✔✔The distal segment of the abdominal
aorta including the bifurcation and proximal segments of both the left and
right common iliac arteries.
Arterial graft (V) - 🧠 ANSWER ✔✔A segment of peripheral artery that is
recovered, processed and preserved.
Autograft (A) - 🧠 ANSWER ✔✔Tissue intended for implantation,
transplantation or infusion into the living donor from whom it was
recovered.
Available for Distribution - 🧠 ANSWER ✔✔the status of an HCT/P upon
verifying and documenting that the HCT/P meets the release criteria on the
basis of a review of manufacturing and tracking records pertaining to the
HCT/P, documented by a responsible person with the date when the
determination that the HCT/P is available for distribution has been made.
Batch - 🧠 ANSWER ✔✔A specific quantity of tissue produced according to
a single processing protocol during the same processing cycle
, Bioburden - 🧠 ANSWER ✔✔The number of contaminating organisms found
on a given amount of material
Birth Tissue (BT) - 🧠 ANSWER ✔✔gestational tissue donated at the time of
delivery of a living newborn. This includes placenta, Wharton's jelly,
amniotic fluid, chorionic membrane, amniotic membrane,
placental/chorionic disc, umbilical veins, and umbilical cord tissue
Cardiac Tissue (C) - 🧠 ANSWER ✔✔Tissue type that includes, but is not
limited to, valved conduits, non-valved conduits, aortoiliac grafts, and patch
grafts
Cellular Tissue (CT) - 🧠 ANSWER ✔✔viable cells that are autologous or
allogeneic, committed or uncommitted, and non-expanded
Cold Ischemic Time (C) - 🧠 ANSWER ✔✔The time interval from subjecting
cardiac tissue to cold rinse (or transport) solution at recovery to the
beginning of disinfection.
Cold Ischemic Time (V) - 🧠 ANSWER ✔✔The time interval from subjecting
vascular tissue to transport solution and wet ice temperatures at recovery
to the beginning of disinfection.
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
3
